Literature DB >> 18259939

The prognostic implications of circulating tumor cells in patients with breast cancer.

Jeffrey B Smerage1, Daniel F Hayes.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18259939     DOI： 10.1080/07357900701784204

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  9 in total

1.  Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker Workshop.

Authors:  Jane P F Bai; Robert Bell; ShaAvhree Buckman; Gilbert J Burckart; Hans-Georg Eichler; Kenneth C Fang; Federico M Goodsaid; William J Jusko; Lawrence L Lesko; Bernd Meibohm; Scott D Patterson; Oscar Puig; Jeffrey B Smerage; Barbara J Snider; John A Wagner; Jingsong Wang; Marc K Walton; Russell Weiner
Journal:  AAPS J       Date:  2011-03-30       Impact factor: 4.009

2.  Nanoresonator chip-based RNA sensor strategy for detection of circulating tumor cells: response using PCA3 as a prostate cancer marker.

Authors:  James A Sioss; Rustom B Bhiladvala; Weihua Pan; Mingwei Li; Susan Patrick; Ping Xin; Stacey L Dean; Christine D Keating; Theresa S Mayer; Gary A Clawson
Journal:  Nanomedicine       Date:  2011-11-22       Impact factor: 5.307

3.  Instrument for fluorescence sensing of circulating cells with diffuse light in mice in vivo.

Authors:  Eric Zettergren; Dwayne Vickers; Judith Runnels; Shashi K Murthy; Charles P Lin; Mark Niedre
Journal:  J Biomed Opt       Date:  2012-03       Impact factor: 3.170

4.  Tomographic sensing and localization of fluorescently labeled circulating cells in mice in vivo.

Authors:  Eric Zettergren; Tushar Swamy; Judith Runnels; Charles P Lin; Mark Niedre
Journal:  Phys Med Biol       Date:  2012-07-02       Impact factor: 3.609

Review 5.  Clinical implications of cancer self-seeding.

Authors:  Elizabeth Comen; Larry Norton; Joan Massagué
Journal:  Nat Rev Clin Oncol       Date:  2011-04-26       Impact factor: 66.675

6.  Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cells.

Authors:  Lihua H Wang; Thomas D Pfister; Ralph E Parchment; Shivaani Kummar; Larry Rubinstein; Yvonne A Evrard; Martin E Gutierrez; Anthony J Murgo; Joseph E Tomaszewski; James H Doroshow; Robert J Kinders
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

7.  Circulating tumor cell analysis: technical and statistical considerations for application to the clinic.

Authors:  Alison L Allan; Michael Keeney
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

8.  Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients.

Authors:  Markus Wallwiener; Sabine Riethdorf; Andreas Daniel Hartkopf; Caroline Modugno; Juliane Nees; Dharanija Madhavan; Martin Ronald Sprick; Sarah Schott; Christoph Domschke; Irène Baccelli; Birgitt Schönfisch; Barbara Burwinkel; Frederik Marmé; Jörg Heil; Christof Sohn; Klaus Pantel; Andreas Trumpp; Andreas Schneeweiss
Journal:  BMC Cancer       Date:  2014-07-11       Impact factor: 4.430

9.  Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.

Authors:  Maren Bredemeier; Philippos Edimiris; Mitra Tewes; Pawel Mach; Bahriye Aktas; Doreen Schellbach; Jenny Wagner; Rainer Kimmig; Sabine Kasimir-Bauer
Journal:  Oncotarget       Date:  2016-07-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.